Intranasal naloxone prevents the development of hypoglycemia-associated autonomic failure (HAAF) in susceptible individuals

Category Primary study
JournalDiabetes
Year 2020
This article has no abstract
Epistemonikos ID: a182170ce8beb0657e5058c2902df4e46a9d9b5f
First added on: Feb 12, 2025